J&J, Medtronic and Abbott Labs Among Massachusetts Financial’s Favorite Healthcare Stocks

Wall St. Watchdog reveals information regarding Massachusetts Financial Services’ top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 66 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $9.152 billion.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Massachusetts Financial Services reported holding 26,203,993 shares with a market value of $1,743,089,526. This comprised 1.84% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 25,836,459 shares with a market value of $1,645,524,038. This comprised 2.05% of the total portfolio. The net change in shares for this position over the two quarters is -367,534. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Medtronic Inc. (NYSE:MDT): On 06/30/2011, Massachusetts Financial Services reported holding 35,157,349 shares with a market value of $1,354,612,614. This comprised 1.43% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 35,256,124 shares with a market value of $1,171,913,621. This comprised 1.46% of the total portfolio. The net change in shares for this position over the two quarters is 98,775. About Company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Massachusetts Financial Services reported holding 22,803,283 shares with a market value of $1,199,908,727. This comprised 1.27% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 22,192,326 shares with a market value of $1,134,915,538. This comprised 1.42% of the total portfolio. The net change in shares for this position over the two quarters is -610,957. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): On 06/30/2011, Massachusetts Financial Services reported holding 16,069,145 shares with a market value of $1,034,692,237. This comprised 1.09% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 21,618,002 shares with a market value of $1,094,735,608. This comprised 1.37% of the total portfolio. The net change in shares for this position over the two quarters is 5,548,857. About Company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Massachusetts Financial Services reported holding 54,794,358 shares with a market value of $1,128,763,796. This comprised 1.19% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 56,091,308 shares with a market value of $991,694,343. This comprised 1.24% of the total portfolio. The net change in shares for this position over the two quarters is 1,296,950. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • St. Jude Medical Inc. (NYSE:STJ): On 06/30/2011, Massachusetts Financial Services reported holding 19,299,686 shares with a market value of $920,209,034. This comprised 0.97% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 19,287,941 shares with a market value of $698,030,558. This comprised 0.87% of the total portfolio. The net change in shares for this position over the two quarters is -11,745. About Company: St. Jude Medical, Inc. develops, manufactures, and distributes medical devices for the worldwide cardiovascular market. The Company serves patients and its health care customers with products and services including heart valves, cardiac rhythm management systems, specialty catheters, and other cardiovascular devices.
  • Becton Dickinson And Company (NYSE:BDX): On 06/30/2011, Massachusetts Financial Services reported holding 8,140,820 shares with a market value of $701,494,444. This comprised 0.74% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 7,708,033 shares with a market value of $565,152,977. This comprised 0.71% of the total portfolio. The net change in shares for this position over the two quarters is -432,787. About Company: Becton, Dickinson and Company manufactures and sells a variety of medical supplies and devices and diagnostic systems. The Company’s products are used by health care professionals, medical research institutions, and the general public. Becton’s products are marketed worldwide.
  • Dentsply International Inc. (NASDAQ:XRAY): On 06/30/2011, Massachusetts Financial Services reported holding 11,557,208 shares with a market value of $440,098,502. This comprised 0.47% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 9,241,572 shares with a market value of $283,623,850. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is -2,315,636. About Company: DENTSPLY International Inc. manufactures and distributes dental supplies on a worldwide basis. The Company’s products include dental prosthetics, endodontic instruments, dental sealants, ultrasonic scalers, dental x-ray equipment, and intraoral cameras. DENTSPLY also provides impression materials, orthodontic appliances, and dental operatory software systems, and other dental products.
  • Quest Diagnostics Inc. (NYSE:DGX): On 06/30/2011, Massachusetts Financial Services reported holding 4,517,425 shares with a market value of $266,979,811. This comprised 0.28% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 3,749,556 shares with a market value of $185,078,086. This comprised 0.23% of the total portfolio. The net change in shares for this position over the two quarters is -767,869. About Company: Quest Diagnostics Incorporated provides diagnostic testing, information, and services. The Company operates a national network of full-service laboratories, rapid response laboratories, and patient service centers. Quest Diagnostics provides esoteric testing, routine medical testing, drugs of abuse testing, and non-hospital-based anatomicpathology testing.
  • Covidien Plc (NYSE:COV): On 06/30/2011, Massachusetts Financial Services reported holding 2,482,141 shares with a market value of $132,124,364. This comprised 0.14% of the total portfolio. On 09/30/2011, Massachusetts Financial Services reported holding 4,182,288 shares with a market value of $184,438,894. This comprised 0.23% of the total portfolio. The net change in shares for this position over the two quarters is 1,700,147. About Company: Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

(Note: Data regarding Massachusetts Financial Services’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>